IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Memorial Sloan Kettering Cancer Center
Hospices Civils de Lyon
Hospital Universitari de Bellvitge
Institut Bergonié
First Affiliated Hospital, Sun Yat-Sen University
Johns Hopkins University
Sun Yat-sen University
State University of New York - Upstate Medical University
Chinese University of Hong Kong
Beth Israel Deaconess Medical Center
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
First People's Hospital of Hangzhou
Southwest Hospital, China
Chinese University of Hong Kong
Institut Bergonié
University Health Network, Toronto
Massachusetts General Hospital
First People's Hospital of Hangzhou
H. Lee Moffitt Cancer Center and Research Institute
University of Aarhus
Taipei Medical University WanFang Hospital
Duke University
Memorial Sloan Kettering Cancer Center
Eastern Hepatobiliary Surgery Hospital
Sohag University
Mayo Clinic
Jonsson Comprehensive Cancer Center
First People's Hospital of Hangzhou
Sun Yat-sen University
University Hospital, Toulouse
Wake Forest University Health Sciences
Jonsson Comprehensive Cancer Center
Seoul National University Hospital
AdventHealth
M.D. Anderson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
Fudan University
Assistance Publique - Hôpitaux de Paris
University of Washington
Universitaire Ziekenhuizen KU Leuven
University Hospitals, Leicester
Brno University Hospital
Chinese PLA General Hospital
Mie University
The First People's Hospital of Changzhou
UMC Utrecht
Kidney Cancer Research Bureau
H. Lee Moffitt Cancer Center and Research Institute